News
News
Immitra Bio receives CHF 150,000 from Venture Kick
The ETH spin-off and Geneva-based company Immitra Bio has received CHF 150,000 from Venture Kick to develop a new treatment…
News
Actival Shines at >>venture>> 2026 Award Ceremony
The annual >>venture>> Awards, held at the Swiss Tech Convention Centre at EPFL in Lausanne in front of around 300…
News
NIRLAB Acquired by 908 Devices
NIRLAB, the Swiss startup behind a handheld near-infrared (NIR) spectroscopy platform, has been acquired by 908 Devices. The $23 Million…
News
AC Immune Receives $4 million from The Vijay and Marie Goradia Charitable Foundation
AC Immune SA, a Swiss clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, announced it will receive a research…
Events
Events
EPHJ
EPHJ is taking place from 16 to 19 June 2026 in Palexpo Geneva This international trade show is dedicated…
Events
Viva Technology
Viva Technology is taking place on 17-20 June 2026 in Paris. Vivatechnology accelerates innovation by connecting startups, tech leaders,…
Events, Featured event
EPHJ 2026 | Diversification from Microtech to Medtech
The conference Diversification from Microtech to Medtech: Opportunities and Challenges organised by Micronarc and BioAlps will take place during the…
Events
BIO US – San Diego
BIO International Convention, the premier event for the biotechnology industry, takes place from 22 to 25 June 2026 in San…
Opportunities
Opportunities
Switzerland – Australia Call For Proposals
Apply before 17 June 2026, the SNSF and the Australia National Health and Medical Research Council (NHMRC) are launching a…
Opportunities
European Academy of Neurology – Start-up Corner
Startups in neurological field can showcase their advancements at the 12th Congress of the European Academy of Neurology (EAN) in…
Opportunities
IFF Awards
Apply until 30 June 2026 for the IFF (Innovation Fribourg Freibourg) Awards, a initiative of Canton of Fribourg to honor…
Opportunities
CAS Personalized Molecular Oncology
Registration is open for the Certificate of Advanced Studies (CAS) in Personalized Molecular Oncology (PMO) — 2026–2027 session! Are you…











